Shaping the Pharmaceutical Landscape with Engaged Analytical Sciences

Overview:
The ninth Annual Symposium on Chemical and Pharmaceutical Structure Analysis (CPSA 2006) will highlight the theme: Shaping the Pharmaceutical Landscape with Engaged Analytical Sciences. Last year’s event brought a spirited technical focus on new analytical technologies and processes in the areas of biomarker, bioanalytical, structural identification, and pharmaceutical profiling. The take-home messages clearly indicated that the pharmaceutical industry is at a crossroad with technology and culture. A focus on analytical performance benchmarks appeared to be the key endeavors that were central to sustain analytical support activities (http://www.milestonedevelopment.com/CPSA/2005/digest2005.html).

This year’s annual meeting will provide a follow up to the progress made last year; new technologies and processes that positively impact the drug discovery and development will be highlighted. CPSA 2006 will focus on the drug discovery/development timeline and the program will be organized according to the major disciplines in pharmaceutical R&D, namely Discovery Biology and Chemistry, ADMET, Clinical Development, and Pharmaceutical Sciences. Each session will highlight the most demanding challenges and the fastest growing areas in these disciplines. The role of engaged analytical sciences will be emphasized to better forecast the impact on the pharmaceutical landscape.

The CPSA symposia and roundtables are highly interactive events where opinion leaders share their experiences and visions on chemical and pharmaceutical structure analysis in a collegial setting. The symposia feature comprehensive perspectives on industry-related issues and needs. First-hand experiences with specific applications and technologies are openly discussed. The vendor sessions and poster sessions provide unique opportunities to promote interest and develop sustainable relations.

Goals
This annual event is specifically geared to the needs of researchers attempting to keep pace with faster development times and marketing managers attempting to benchmark emerging trends. A goal of this meeting will be to delineate the importance and urgency of enabling analytical sciences at the frontier of pharmaceutical R&D.

Program Chair
Jing-Tao Wu, Millennium Pharmaceuticals

Plenary Lecture
Mark L. Powell, Bristol-Myers Squibb

Keynote Lectures
Richard C. King, Merck Research Laboratories
David M. Lubman, University of Michigan

Symposia Feature
Industry Issues and Needs - Analysis Strategies, Performance Benchmarks

Roundtables Feature
Commercial Technology, Mainstream Applications & Analysis Trends

CPSA - Where Technology and Solutions Meet